Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
02-Jun-2025 | 3,153 | 3,160 | 3,102 | 3,127.8 | 50,613 | 1,10,21,25,778.3 | 2,19,269 |
03-Jun-2025 | 3,132 | 3,156 | 3,113.6 | 3,135 | 44,654 | 1,34,11,38,465.3 | 2,95,117 |
04-Jun-2025 | 3,120 | 3,156.6 | 3,108.8 | 3,137.1 | 39,307 | 1,13,83,62,239.8 | 2,53,736 |
05-Jun-2025 | 3,139 | 3,169.8 | 3,133.4 | 3,141.7 | 30,192 | 79,45,17,775.3 | 1,70,167 |
06-Jun-2025 | 3,141 | 3,163.2 | 3,132.7 | 3,154.3 | 14,089 | 27,26,29,238.2 | 50,297 |
09-Jun-2025 | 3,160 | 3,185.7 | 3,146.2 | 3,180.7 | 13,112 | 35,25,03,257.7 | 66,622 |
10-Jun-2025 | 3,187 | 3,237.6 | 3,177.9 | 3,221 | 32,122 | 81,69,62,163.7 | 1,46,436 |
11-Jun-2025 | 3,220 | 3,224.9 | 3,185.3 | 3,205.8 | 19,304 | 57,27,34,518.4 | 1,11,087 |
12-Jun-2025 | 3,205.8 | 3,269.9 | 3,200.1 | 3,258.8 | 59,270 | 2,90,41,44,092.4 | 5,79,874 |
13-Jun-2025 | 3,175 | 3,259 | 3,175 | 3,252.5 | 49,268 | 1,33,51,19,889.6 | 2,10,047 |
16-Jun-2025 | 3,250 | 3,288.8 | 3,215.9 | 3,275.8 | 37,234 | 1,36,26,04,614.3 | 2,84,309 |
17-Jun-2025 | 3,275.8 | 3,295 | 3,247.2 | 3,255.4 | 31,565 | 99,74,88,438.8 | 2,07,745 |
18-Jun-2025 | 3,254 | 3,254.9 | 3,214 | 3,227 | 39,643 | 76,87,37,183.8 | 1,46,513 |
19-Jun-2025 | 3,245 | 3,245 | 3,150 | 3,164 | 23,309 | 73,31,38,738.3 | 1,31,063 |
20-Jun-2025 | 3,174.9 | 3,195 | 3,150.6 | 3,167.2 | 29,088 | 97,55,58,933.7 | 2,08,156 |
23-Jun-2025 | 3,146.2 | 3,178.9 | 3,140.1 | 3,165.5 | 33,861 | 1,11,40,10,413.8 | 2,34,858 |
24-Jun-2025 | 3,183.6 | 3,192.2 | 3,154.1 | 3,180.9 | 22,192 | 56,17,09,897.7 | 95,216 |
25-Jun-2025 | 3,180.9 | 3,233 | 3,165 | 3,226.7 | 29,604 | 86,65,18,050.2 | 1,60,514 |
26-Jun-2025 | 3,241.6 | 3,241.6 | 3,171.9 | 3,222.5 | 32,954 | 1,17,52,85,916.4 | 1,97,364 |
27-Jun-2025 | 3,350 | 3,377 | 3,287 | 3,341.4 | 1,09,497 | 5,78,93,94,699.3 | 8,26,436 |
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
